Pleliminary results for the 2011 financial year

  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.
Preliminary results 2011


Today the Management Board of Curanum AG has prepared the consolidated financial
statements for the 2011 financial year, which remain preliminary until
certification by the auditor, and approval by the Supervisory Board. The
following are the key points of the financial statements that have been prepared
using International Financial Reporting Standards (IFRS):

Positive revenue trends

In the 2011 financial year consolidated revenue rose by EUR 9.1 million to reach
EUR 265.9 million. A higher occupancy of our residential homes and the opening
of two homes in 2010 and 2011 contributed EUR 5.5 million to this increase, the
six institutions acquired from the GWA group contributed EUR 3.6 million.

Slightly improved operating trends

The Curanum Group reported EBITDA of EUR 27.0 million before one-off effects
(previous year: EUR 26.3 million). The increase of earnings of the established
institutions of EUR 2.8 million and of the new institutions of GWA of EUR 0.4
million is opposed by central up-front costs of EUR 2.5 million.

Earnings marked by one-off effects

Earnings before interest and tax (EBIT) before impairment add up to EUR 14.1
million (previous year: EUR 9.5 million). The annual financial statement is
marked by extraordinary adjustments of value adding up to EUR 22.2 million
(previous year: EUR 16.5 million). Source for this were primarily the agreed
measures relating to reorganization concepts concerning real estates.
Consequently earnings after tax of minus EUR 12.9 million (previous year: minus
EUR 15.8 million) are reported.

Improved financial figures

Cash flow of the CURANUM Group added up to EUR 5.3 million. The inflow of cash
from operating activities adding up to EUR 19.9 million was slightly higher than
the average of the past years. Consequently net financial dept decreased by
about a fifth now amounting to EUR 51 million. This means a ratio of 108%
between net financial dept and equity (previous year: 125%).

Munich, February 15, 2012
The Management Board

Further inquiry note:
Caroline Lutz
Tel.: + 49 89 242065 0

end of announcement                               euro adhoc 

issuer:      CURANUM AG
             Engelbertstraße 23-25
             D-81241 München
phone:       +49 (0)89 242065 60
FAX:         +49 (0) 89 242065 10
sector:      Healthcare Providers
ISIN:        DE0005240709
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Hamburg, Düsseldorf, Stuttgart, regulated
             dealing: München, regulated dealing/prime standard: Frankfurt 
language:   English

Weitere Meldungen: CURANUM AG

Das könnte Sie auch interessieren: